CJC-1295 / Ipamorelin 10 mg

CJC-1295 / Ipamorelin 10MG is a dual-peptide research blend combining two extensively studied growth hormone secretagogues. CJC-1295 is a synthetic Growth Hormone-Releasing Hormone (GHRH) analog, while Ipamorelin is a selective Growth Hormone Secretagogue Receptor (GHSR) agonist. Together, they have been widely investigated for their ability to support endogenous growth hormone signaling in laboratory research. Researchers have explored this peptide combination for its role in growth hormone regulation, metabolic function, body composition, muscle biology, recovery pathways, and endocrine research. The complementary mechanisms of CJC-1295 and Ipamorelin make this blend a valuable tool for advanced peptide and hormone-related studies.

Key Features

• Dual-peptide blend containing CJC-1295 and Ipamorelin
• High-purity lyophilized research peptide
• Investigated for endogenous growth hormone signaling
• Commonly studied in metabolism and body composition research
• Research interest in muscle biology, recovery, and endocrine function
• Intended exclusively for laboratory and scientific research

Research Use Notice

CJC-1295 / Ipamorelin 10MG is an investigational research peptide blend intended exclusively for laboratory and scientific research purposes. This product is not approved for human or veterinary use and is not intended to diagnose, treat, cure, or prevent any disease.

Short Marketing Version

CJC-1295 / Ipamorelin 10MG combines two well-established growth hormone research peptides into a single high-purity formulation. Widely studied for growth hormone signaling, metabolic research, and endocrine biology, this peptide blend provides researchers with a premium tool for advanced laboratory investigations. Intended exclusively for research use.